Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets open in 20 minutes
NZX 50
11,938.08
+64.08
(+0.54%)
NZD/USD
0.6011
+0.0049
(+0.82%)
ALL ORDS
7,897.50
+48.10
(+0.61%)
OIL
77.99
-0.12
(-0.15%)
GOLD
2,310.10
+1.50
(+0.06%)
Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.47
+0.25
(+1.30%)
At close: 04:00PM EDT
19.47
0.00
(0.00%)
After hours:
05:29PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
30/06/2020
Total revenue
753,200
753,200
678,400
690,600
638,600
Cost of revenue
236,200
236,200
202,000
197,600
186,100
Gross profit
517,000
517,000
476,400
493,000
452,500
Operating expenses
Research development
88,700
88,700
85,400
81,900
77,200
Selling general and administrative
572,900
572,900
514,700
537,800
507,300
Total operating expenses
661,600
661,600
600,100
619,700
584,500
Operating income or loss
-144,600
-144,600
-123,700
-126,700
-132,000
Interest expense
2,900
2,900
3,200
6,600
10,800
Total other income/expenses net
-117,200
-117,200
-16,300
75,500
-83,500
Income before tax
-262,200
-262,200
-140,600
-57,100
-223,300
Income tax expense
1,100
1,100
-28,600
-29,900
-23,700
Income from continuing operations
-263,300
-263,300
-112,000
-27,200
-199,600
Net income
-263,300
-263,300
-112,000
-27,200
-199,500
Net income available to common shareholders
-263,300
-263,300
-112,000
-27,200
-199,500
Basic EPS
-3.09
-3.18
-1.39
-0.35
-2.69
Diluted EPS
-3.09
-3.18
-1.39
-0.35
-2.69
Basic average shares
74,750
82,800
80,600
78,000
74,300
Diluted average shares
74,750
82,800
80,600
78,000
74,300
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.